Site(s) of metastases-Liver Posts on Medivizor
Navigation Menu

Site(s) of metastases-Liver Posts on Medivizor

Evaluating the effectiveness and safety of TAS-102 plus Yttrium-90 radioembolization for the treatment of patients with colorectal cancer liver metastasis.

Evaluating the effectiveness and safety of TAS-102 plus Yttrium-90 radioembolization for the treatment of patients with colorectal cancer liver metastasis.

Posted by on Oct 22, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of TAS-102 (Lonsurf; trifluridine-tipiracil) plus Yttrium-90 (Y-90) radioembolization (RE) for patients with colorectal cancer liver metastasis (CRLM) who are unresponsive to chemotherapy. The data showed that TAS-102 plus RE was safe and effective in these patients. Some background...

Read More

Adding everolimus to letrozole in premenopausal patients with hormone-positive advanced breast cancer

Adding everolimus to letrozole in premenopausal patients with hormone-positive advanced breast cancer

Posted by on Jun 6, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the effects and outcomes of adding everolimus (EVE; Afinitor) plus letrozole (LET; Femara) to hormonal therapy for the treatment of premenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (BC). The data showed that the combination of EVE+LET improved survival...

Read More

Comparing surgery options for patients with colorectal cancer that has spread to the liver

Comparing surgery options for patients with colorectal cancer that has spread to the liver

Posted by on May 8, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate 2 treatment options for patients with colorectal cancer (CRC) that has spread to the liver. The study found that patients who underwent associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) had better outcomes compared to those who had 2-stage hepatectomy...

Read More

Bevacizumab plus chemotherapy and deep electro-hyperthermia improves the outcomes of patients with advanced colon cancer

Bevacizumab plus chemotherapy and deep electro-hyperthermia improves the outcomes of patients with advanced colon cancer

Posted by on Dec 20, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of bevacizumab plus chemotherapy and deep electro-hyperthermia (DEH) for advanced colon cancer (CC). Researchers suggested that this treatment improves the outcomes of these patients.  Some background Colorectal cancer is a common cancer worldwide. Around 50-60% of these patients...

Read More

Are immune checkpoint inhibitors effective for non-small-cell lung cancer spread to the brain or liver?

Are immune checkpoint inhibitors effective for non-small-cell lung cancer spread to the brain or liver?

Posted by on Dec 6, 2020 in Lung cancer | 0 comments

In a nutshell This study was carried out to look at the effectiveness of immune checkpoint inhibitors (ICI) in non-small cell cancer (NSCLC) patients with different sites of cancer spread. The authors found that ICIs could significantly improve the overall survival (OS) of patients NSCLC spread to the brain or liver compared to conventional...

Read More

Evaluating the timing of chemotherapy plus bevacizumab for patients with colorectal cancer and liver metastasis

Evaluating the timing of chemotherapy plus bevacizumab for patients with colorectal cancer and liver metastasis

Posted by on Oct 24, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether chemotherapy plus bevacizumab (Avastin) before and after or after surgery improves the survival of patients with colorectal cancer (CRC) and operable liver metastasis (LM; cancer spread to the liver). Researchers suggested that chemotherapy and bevacizumab before and after...

Read More

Bevacizumab plus mFOLFOX6 improves the outcomes of patients with colorectal cancer and liver metastasis

Bevacizumab plus mFOLFOX6 improves the outcomes of patients with colorectal cancer and liver metastasis

Posted by on Sep 9, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of bevacizumab (Avastin) combined with mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) treatment in RAS-positive advanced colorectal cancer (CRC). Researchers suggested that this treatment improved the treatment and survival outcomes of patients with CRC and liver metastasis (spread to the...

Read More

Metastasis surgery improves survival of patients with advanced colorectal cancer

Metastasis surgery improves survival of patients with advanced colorectal cancer

Posted by on Jan 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the survival outcomes of patients who underwent surgery for colorectal cancer (CRC) metastasis (spread to other parts of the body). Researchers suggested that metastasis surgery is associated with survival improvement in these patients. Some background CRC is one of the most common cancers worldwide. A...

Read More

Robotic versus laparoscopic liver surgery is a safe treatment for metastatic colorectal cancer

Robotic versus laparoscopic liver surgery is a safe treatment for metastatic colorectal cancer

Posted by on Dec 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of robotic-assisted liver surgery (RALS) compared to laparoscopic liver surgery (LLS) in advanced colorectal cancer. Researchers suggested that RALS is similarly safe and effective as LLS for these patients. Some background Colorectal cancer is one of the most common cancers worldwide....

Read More

Looking for participants to test a vaccine for the treatment of advanced colorectal cancer

Looking for participants to test a vaccine for the treatment of advanced colorectal cancer

Posted by on Sep 10, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1b trial is examining the effectiveness and safety of a vaccine treatment, ATP128, in the treatment of advanced colorectal cancer. The main outcome to be measured is the tumor response to the treatment and treatment toxicity. This trial is being conducted in Arizona and California, US. The details Colorectal cancer is the...

Read More

Liver surgery is a safe treatment for patients with BRAF-positive colorectal cancer liver metastasis

Posted by on Jul 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of patients with BRAF-positive colorectal cancer liver-metastasis (CRLM; spread to the liver) undergoing surgery. Researchers suggested that surgery is associated with improved outcomes for these patients. Some background Colorectal cancer is one of the most common cancers in the US. Around 25% of...

Read More